OCN Questions and Answers 100% Verified
relative risk A comparison of the risk of some health-related event such as disease or
death in two groups.
Phase 1 clinical trials Safety/efficacy (1st time w/humans)
Phase 2 clinical trials Effectiveness in different tumors
Phase 3 clinical trials Compared to standard therapy
Phase 4 clinical trials Add to information (side effects/risks)
Beneficence Principles of doing good
Nonmaleficence Principles of doing no harm
, Sodium thiosulfate Extravasation Antidote for Alkylating Agents
Totect Extravasation Antidote for Anthracyclines
Ice Extravasation treatment for Taxanes
Topical DMSO/cold Extravasation treatment for Antitumor Antibiotics
Hyaluronidase
Primary prevention Preventing of any occurance of disease. (Interventions that focus on
reducing the risk of cancers in individuals and groups)
Prevention The most effective treatment for cancer
Phase 1 clinical trials Safety/efficacy (1st time w/humans)
Phase 2 clinical trials Effectiveness in different tumors
relative risk A comparison of the risk of some health-related event such as disease or
death in two groups.
Phase 1 clinical trials Safety/efficacy (1st time w/humans)
Phase 2 clinical trials Effectiveness in different tumors
Phase 3 clinical trials Compared to standard therapy
Phase 4 clinical trials Add to information (side effects/risks)
Beneficence Principles of doing good
Nonmaleficence Principles of doing no harm
, Sodium thiosulfate Extravasation Antidote for Alkylating Agents
Totect Extravasation Antidote for Anthracyclines
Ice Extravasation treatment for Taxanes
Topical DMSO/cold Extravasation treatment for Antitumor Antibiotics
Hyaluronidase
Primary prevention Preventing of any occurance of disease. (Interventions that focus on
reducing the risk of cancers in individuals and groups)
Prevention The most effective treatment for cancer
Phase 1 clinical trials Safety/efficacy (1st time w/humans)
Phase 2 clinical trials Effectiveness in different tumors
